25 Nov 20 | EU | Bio-Thera Solutions announces it has submitted a marketing authorisation application for BAT1706 (proposed bevacizumab biosimilar) in EU.

22 Nov 20 | All | Innovent releases results of Ph III trials of Tyvyt® (sintilimab) with Byvasda® (biosimilar bevac...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags